The Cigna Group vs Abbvie Inc.
CI vs ABBV — side-by-side comparison from reported financials. CI leads 6, ABBV leads 6 of 12 comparable metrics.
The Cigna Group
CI · Healthcare
$282.43+0.50%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | CI | ABBV |
|---|---|---|
| Price | $282.43 | $276.43 |
| Market cap | $74.6B | $488B |
| Revenue (TTM) | $282B | $64.4B |
| Revenue growth | +15.1% | +1.8% |
| Net margin | 2.3% | 9.8% |
| Free cash flow | $10.3B | $18.2B |
| Net cash (debt) | ($22.7B) | ($56.2B) |
| 1-year price return | -7.7% | +19.8% |
| P/E | 11.6 | 77.4 |
| P/E vs own history (cheap-side %) | 80% | 23% |
| Dividend yield | 2.18% | 2.45% |
| Return on equity | 15% | 96% |
| Altman Z-score | 1.77 | 2.33 |
| CV checks passed | 10 of 11 | 9 of 11 |
| Employees | 67,700 | 57,000 |
Full résumé-style profiles: CI CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.